OneOncology names CEO
Jeff Patton, MD, has been named CEO of OneOncology, a national partnership of independent community oncologists.
Patton — who will continue as executive chairman of the board at Tennessee Oncology — has served as acting CEO and president of physician services for OneOncology since February.
“Dr. Patton is a visionary leader with high integrity who understands community oncology and how practices can thrive in today’s changing environment better than anyone else in the country,” David Chernow, OneOncology’s chairman of the board, said in a press release. “Especially in the wake of the COVID-19 pandemic, Dr. Patton’s leadership, vision and track record of success are exactly the necessary ingredients to continue OneOncology's momentum and help its partner practices grow.”
OneOncology is comprised of five practices throughout the U.S. representing more than 400 providers who treat approximately 250,000 patients each year at 160 sites.
OneOncology partner practices deliver integrated oncology care services across the continuum of care, from screening and diagnosis to clinical trials, therapies, survivorship and end-of-life care.
“I’m honored to lead such a dynamic partnership that helps community oncology practices grow and care for their patients,” Patton said in the release. “We formed OneOncology in 2018 with the idea that with physician leadership, common technology platforms and access to capital, practices could have both the necessary scale and local decision-making authority needed to not only survive but thrive in today’s marketplace. ... As practices grapple with COVID-19 and plan for caring for patients post peak, the ideas that brought us together are exactly what will propel our future growth.”